Our Technology

We are advanced sensor & AI scientists with 20 years of experience focused on producing technologies to make interior spaces safe, improve industrial processes, and reduce the carbon footprint.

Since March of 2020, we have been focused on the detection and elimination of the SARS-CoV-2 virus. We have designed this SARS-CoV-2 technology to be portable, wearable, and technology transferable to a multitude of applications.

We have incorporated the science and lab tests of the National Institutes of Health (NIH) into our technology.

As December 2020, we have achieved the science/technology of this goal. Now we need to build and test.

SARS-CoV-2 Virus

Over the past 9 months InnoVita has produced new technologies for the detection and elimination of the SARS-CoV-2 virus.

Industrial Process Optimization

Using our own AI technology we have optimized and simultaneously reduced the carbon footprint for Power Plants, Paper Machines, Lime Kilns, Turbine Blade Manufcturing, and other industrial processes.

Power Grid Optimization

We optimized the load demand forecast for the New England Power Grid in 2000. From there we produced an electrical forecast pricing product. In 2008 we were acquired.

Predictive Emissions Monitoring System

We were one of the first companies in the World (1999) to have our Predictive Emissions Monitoring System (PEMS) technology approved by the EPA.

SARS-CoV-2 (Covid-19) Pandemic & Our Reponse

Detection

We are utilizing human exhalation biomarkers along with our sensor technology which employs our Active Sampling Neural Network (ASNN), to detect the electro-chemical response signature of the SARS-CoV-2 virus.
Elimination

We developed a new Ultraviolet viral sterilization technology based specifically on the SARS-CoV-2 virus and the National Institutes of Healths’s (NIH) science and lab tests. Our technology exceeds the NIH’s 99.9% SARS-CoV-2 lab sterilization results by 645%.
Verification

We use our ASNN detection technolgy to verify the elimination of the SARS-CoV-2 virus. Our ASNN tehnology is sensitive enough to detect the SARS-CoV-2 biomarkers in the parts-per-billion range.

Our Team

Ramin Abrishamian Chief Executive Officer

30 years of operational experience developing new technologies, commercializing them and growing companies based on them.

Joseph Conroy Chief Technology Officer

20 year advanced sensor and AI technology visionary and architect. Joe has already filed 2 of 5 patents in advanced sensors and AI technology for the SARS-CoV-2 virus.